Document is current
Any future updates will be listed below
-
Authors
Deng, Gary
Giralt, Sergio
Chung, David J.
Landau, Heather
Siman, Jonathan
Search, Benjamin
Coleton, Marci
Vertosick, Emily
Shapiro, Nathan
Chien, Christine
Wang, Xin S.
Cassileth, Barrie
Mao, Jun J.
-
Funding
Funding for this research was provided by:
Gateway for Cancer Research
MSK Integrative Medicine and Translational Research Grant
NIH/NCI Cancer Center Support Grant (P30 CA008748)
AC Israel Foundation
Byrne Fund
- License Information
-
More Information
Article History
Received: 18 May 2017
Accepted: 11 September 2017
First Online: 17 September 2017
Compliance with ethical standards
: This study was approved by the Institutional Review Board (IRB) at Memorial Sloan Kettering Cancer Center. All procedures performed were in accordance with the ethical standards of the institutional research committee.
: Informed consent was obtained from all individual participants included in the study.
: Dr. Giralt has received honoraria from Celgene, Takeda, Amgen, Jazz, and Sanofi; served in a consulting/advisory role for Celgene, Takeda, Sanofi, Jazz, Amgen, and Janssen; received research funding from Celgene and Takeda. Dr. Landau has received honoraria from Takeda; served in a consulting/advisory role for Onyx, Spectrum, Takeda, and Prothena; received research funding from Onyx. The remaining authors declare no competing financial interests.
: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
